D. E. Shaw & Co., Inc. Gilead Sciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,012,462 shares of GILD stock, worth $116 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,012,462

Previous 741,201 36.6%

Holding current value

$116 Million

Previous $62.1 Million 50.53%

% of portfolio

0.08%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$83.95 - $97.9 $22.8 Million - $26.6 Million	271,261 Added 36.6%	1,012,462 $93.5 Million
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $173 Million - $218 Million	-2,597,051 Reduced 77.8%	741,201 $62.1 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $139 Million - $161 Million	2,203,342 Added 194.14%	3,338,252 $229 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $12.8 Million - $15.6 Million	178,269 Added 18.63%	1,134,910 $83.1 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $101 Million - $114 Million	-1,373,449 Reduced 58.94%	956,641 $77.5 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $20.7 Million - $22.6 Million	279,963 Added 13.66%	2,330,090 $175 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $16.1 Million - $18.4 Million	212,149 Added 11.54%	2,050,127 $158 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $13.8 Million - $15.7 Million	-178,062 Reduced 8.83%	1,837,978 $152 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $97.5 Million - $140 Million	1,563,996 Added 345.98%	2,016,040 $173 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $78.6 Million - $89.7 Million	-1,319,616 Reduced 74.48%	452,044 $27.9 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $195 Million - $219 Million	-3,373,926 Reduced 65.57%	1,771,660 $110 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $258 Million - $323 Million	4,454,256 Added 644.3%	5,145,586 $306 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $5.33 Million - $6.05 Million	82,163 Added 13.49%	691,330 $50.2 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $14.3 Million - $16.3 Million	238,201 Added 64.21%	609,167 $39.4 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $2.55 Million - $2.91 Million	45,059 Added 13.83%	370,966 $21.6 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $6.49 Million - $8.15 Million	-104,436 Reduced 24.27%	325,907 $20.6 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $38.9 Million - $45.2 Million	-538,092 Reduced 55.56%	430,343 $33.1 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $243 Million - $311 Million	-3,881,635 Reduced 80.03%	968,435 $72.4 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $41.4 Million - $45.5 Million	-671,287 Reduced 12.16%	4,850,070 $315 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $41.4 Million - $45.7 Million	-662,256 Reduced 10.71%	5,521,357 $350 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $13.5 Million - $15.2 Million	-218,887 Reduced 3.42%	6,183,613 $418 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $251 Million - $281 Million	4,014,025 Added 168.06%	6,402,500 $416 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $24.1 Million - $31.5 Million	398,815 Added 20.04%	2,388,475 $149 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $54.1 Million - $59.9 Million	759,460 Added 61.73%	1,989,660 $154 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $22.2 Million - $25.8 Million	-341,546 Reduced 21.73%	1,230,200 $87.1 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $8.37 Million - $10.2 Million	-114,887 Reduced 6.81%	1,571,746 $118 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $74.3 Million - $87.2 Million	-1,043,704 Reduced 38.23%	1,686,633 $121 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $197 Million - $233 Million	2,730,337	2,730,337 $221 Million

Others Institutions Holding GILD

# of Institutions

2,098

Shares Held

1.02B

Call Options Held

8.73M

Put Options Held

9.63M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $143B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account